Key result
Pretreatment with isoflurane or sevoflurane abolished the marked reductions in left ventricular developed pressure caused by platelet-activating factor-stimulated neutrophils in isolated rat hearts.
Why the study?
Does pretreatment with isoflurane or sevoflurane prevent neutrophil-induced contractile dysfunction in isolated rat hearts?
Does pretreatment with isoflurane or sevoflurane prevent neutrophil-induced contractile dysfunction in isolated rat hearts?
Isoflurane and sevoflurane precondition the heart against neutrophil-induced contractile dysfunction, likely by inhibiting neutrophil adherence and increasing resistance to oxidant injury.
Answers are grounded in this paper and cite their sources.
May protect isolated rat hearts from neutrophil injury; leaves open clinical translation of volatile anesthetic preconditioning.
BACKGROUND: The authors tested the hypothesis that pretreatment with isoflurane or sevoflurane can protect the heart against neutrophil-induced contractile dysfunction. METHODS: Studies were conducted in buffer-perfused and paced isolated rat hearts. Left ventricular developed pressure served as an index of contractility. Pretreatment consisted of administration of 1.0 minimum alveolar concentration isoflurane or sevoflurane for 15 min followed by a 10-min washout and was performed in the absence and presence of the adenosine triphosphate-sensitive potassium channel inhibitor glibenclamide (10 microM). Polymorphonuclear neutrophils and platelet-activating factor were then added to the perfusate for 10 min, followed by 30 min of recovery. Neutrophil retention was assessed from the difference between those administered and collected in coronary effluent and measurements of myeloperoxidase in myocardial samples. Isolated hearts were also used to assess the effect of volatile anesthetic pretreatment on cardiac dysfunction caused by enzymatically generated superoxide. In additional studies, the authors evaluated the effect of volatile anesthetic pretreatment on the adherence of neutrophils to isolated rat aortic segments. RESULTS: Platelet-activating factor-stimulated neutrophils caused marked and persistent reductions (> 50%) in left ventricular developed pressure. Pretreatment with either isoflurane or sevoflurane abolished these effects, as well as the associated increases in neutrophil retention. Glibenclamide did not alter these actions of the anesthetics. Pretreatment with either volatile anesthetic attenuated the reductions in left ventricular developed pressure caused by exogenous superoxide and abolished the increases in neutrophil adherence in the aortic segments. CONCLUSION: Isoflurane and sevoflurane preconditioned the heart against neutrophil-induced contractile dysfunction. This action was associated with an inhibition to neutrophil adherence and likely involved an increased resistance of the myocardium to oxidant-induced injury; the adenosine triphosphate-sensitive potassium channels played no apparent role.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2004) studied Neutrophil-induced contractile dysfunction. Isoflurane or sevoflurane vs. No pretreatment was evaluated on Left ventricular developed pressure. Pretreatment with isoflurane or sevoflurane abolished the marked reductions in left ventricular developed pressure caused by platelet-activating factor-stimulated neutrophils in isolated rat hearts.
Synapse has enriched 10 related papers. Consider them for comparative context: